**Core Concept**
The patient's symptom, epistaxis (nosebleed) during menstruation, is likely related to a condition that affects blood coagulation or platelet function. The underlying principle being tested is the relationship between hormonal changes and bleeding disorders.

**Why the Correct Answer is Right**
The patient is most likely suffering from **Hereditary Hemorrhagic Telangiectasia (HHT)**, also known as Osler-Weber-Rendu syndrome. HHT is a genetic disorder characterized by the formation of abnormal blood vessels, leading to telangiectasias (dilated blood vessels) and an increased risk of epistaxis, particularly during menstruation. The condition is often associated with mutations in the ENG, ACVRL1, or SMAD4 genes, which play a crucial role in the TGF-beta signaling pathway involved in angiogenesis (formation of new blood vessels).

**Why Each Wrong Option is Incorrect**
* **Option A:** **Idiopathic Thrombocytopenic Purpura (ITP)** is a bleeding disorder characterized by low platelet count, but it is not typically associated with epistaxis during menstruation.
* **Option B:** **Von Willebrand Disease** is a bleeding disorder caused by a deficiency or dysfunction of von Willebrand factor, but it is not typically associated with epistaxis during menstruation.
* **Option C:** **Hemophilia A** is a bleeding disorder caused by a deficiency of factor VIII, but it is not typically associated with epistaxis during menstruation.

**Clinical Pearl / High-Yield Fact**
HHT is often associated with other manifestations, including gastrointestinal telangiectasias, pulmonary arteriovenous malformations, and cerebral arteriovenous malformations.

**Correct Answer:** C.